H2020 EU New developments in Industrial Biocatalysis demonstration workshop
Date and time
Location
DECHEMA, Max Buchner Lecture Hall
Theodor-Heuss-Allee 25 60486 Frankfurt am Main GermanyDescription
This workshop will explore the state of the art in industrial biocatalysis through the new technologies developed in the EU Horizon 2020 projects ROBOX and CARBAZYMES.
Preliminary programme:
10:00 Welcome and Introduction to the workshop
10:10 Introduction to ROBOX - Marco Fraaije project coordinator
10:20 Engineering oxidative enzymes
10:40 Producing oxidative enzymes
11:00 Industrial applications of P450 monooxygenases, Oxidases and
Baeyer-Villiger monooxygenases Martin Schürmann / Innosyn
11:40 Using oxidative enzymes for surface modifications Geert Deroover/ ChemStream
12:20 Lunch & Posters
14:20 Introduction to Carbazymes
Woody Fessner - project coordinator
14:30 Discovery & engineering of C-C bond forming enzymes
Woody Fessner / TU Darmstadt
15:00 Production of maximally diverse panels of novel enzymes
Simon Charnock / Prozomix
15:30 Insights into the application of C-C bond forming enzymes in an industrial environment
Rainer wardenga / Enzymicals
16:00 High substrate loadings & selectivity: Industrially-sound enzymatic C-C bond forming reactions
Pablo Domínguez / Sustainable Momentum
16:30 Close followed by, Networking Reception
ROBOX: Expanding the industrial use of Robust Oxidative Biocatalysts for the conversion and production of alcohols
Oxygen functionalities are key functional groups in many of today’s chemicals and materials. The efficient introductions of oxygen-functionalities into raw materials are key chemical transformations in bulk and fine chemicals. Innovative biocatalytic oxidation routes using molecular oxygen under benign and mild conditions can greatly improve the sustainability and economics of processes. Such processes have so far mainly been applied in the pharmaceuticals sector, where the enzyme-catalyzed step often represents the highest added value, and the high product price (> €1000/kg) justifies suboptimal enzyme production and limitations in catalytic efficiency. In order to achieve broader industrial application of enzymatic biooxidation processes in larger volume but lower price chemical markets, ROBOX has targeted demonstration of the techno-economic viability of biotransformations catalysed by four types of robust oxidative enzymes: P450 monooxygenases, Baeyer-Villiger MonoOxygenase, Alcohol Dehydrogenases and Alcohol Oxidases.
CARBAZYMES: Sustainable industrial processes based on a C-C bond-forming enzyme platform
C-C bond forming reactions are of central importance in industrial organic synthesis to create relevant new molecules from readily available material. However, the implementation of biocatalytic carboligation processes has remained a promising but largely unexplored potential due to a number of technical hurdles. CARBAZYMES has addressed such challenges through an interdisciplinary approach to achieve the biocatalytic synthesis of APIs and bulk chemicals corresponding to market needs. CARBAZYMES has targeted the biocatalytic synthesis of products identified by industrial partners in the consortium to meet market needs. The project targets syntheses at technical scale using a broad platform of 4 types of unique C-C bond-forming enzymes, as well as the capabilities to rapidly evolve those biocatalysts to operate under industrial process conditions.
Registration is free, including lunch and a networking reception. Please remember that non-attendance may still incur costs, so please notify the organiser as soon as possible if you are unable to attend for any reason.
Organised by
This workshop is a join event organised Dr John Whittall on behalf of the project consortia of ROBOX and CARBAZYMES. John is
ROBOX has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No 635734
CARBAZYMES has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No 635595
Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.